Crossmark

Efficacy and safety of nemolizumab in prurigo nodularis: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1016/j.abd.2025.501210

Published Print: 2025-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Vieira, Ana Carolina Putini https://orcid.org/0009-0001-8714-2962
Cruz Akabane, Maria Antônia Costa https://orcid.org/0009-0000-3194-1549
Caletti, Gianna Carolinne Graff https://orcid.org/0009-0003-7620-2119
Heffel, Kélen Klein https://orcid.org/0000-0002-1434-1872
Tauana Oliveira e Silva, Amanda https://orcid.org/0000-0001-5875-0240
License Information

Text and Data Mining valid from 2025-11-01

Text and Data Mining valid from 2025-11-01

Version of Record valid from 2025-09-23
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of nemolizumab in prurigo nodularis: a systematic review and meta-analysis of randomized controlled trials

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2025.501210

Content Type: article

Copyright: © 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.